Outlook Therapeutics, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Outlook Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2015 to 2023.
  • Outlook Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was $44.4M.
  • Outlook Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$94M, a 55.9% decline year-over-year.
  • Outlook Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$59M, a 10.7% increase from 2022.
  • Outlook Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$66.1M, a 24.2% decline from 2021.
  • Outlook Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$53.2M, a 50.9% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$59M +$7.07M +10.7% Oct 1, 2022 Sep 30, 2023 10-K 2023-12-22
2022 -$66.1M -$12.9M -24.2% Oct 1, 2021 Sep 30, 2022 10-K 2023-12-22
2021 -$53.2M -$17.9M -50.9% Oct 1, 2020 Sep 30, 2021 10-K 2022-12-29
2020 -$35.2M -$716K -2.07% Oct 1, 2019 Sep 30, 2020 10-K 2021-12-23
2019 -$34.5M -$4.43M -14.7% Oct 1, 2018 Sep 30, 2019 10-K 2020-12-23
2018 -$30.1M +$8.76M +22.5% Oct 1, 2017 Sep 30, 2018 10-K 2019-12-19
2017 -$38.8M +$14.5M +27.1% Oct 1, 2016 Sep 30, 2017 10-K 2018-12-18
2016 -$53.3M -$5.91M -12.5% Oct 1, 2015 Sep 30, 2016 10-K 2017-12-29
2015 -$47.4M Oct 1, 2014 Sep 30, 2015 10-K 2016-12-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.